Table 1 Patients’ characteristics
Plasma PROK1 positive (%) | Plasma PROK1 negative (%) | P value | |
|---|---|---|---|
All cases | 43 (33.1) | 87 (66.9) | |
Gender | 0.27 | ||
Male | 20 (28.6) | 50 (71.4) | |
Female | 23 (38.3) | 37 (61.7) | |
Age | 0.57 | ||
< 65 | 20 (36.4) | 35(63.6) | |
≧ 65 | 23 (30.7) | 52 (69.3) | |
Location | 0.44 | ||
Right colon | 17 (38.6) | 27 (61.4) | |
Left colon | 26 (30.2) | 60 (69.8) | |
Histological type | 0.5 | ||
Well+mod+pap | 38 (31.9) | 81 (68.1) | |
Por or muc | 5 (45.5) | 6 (54.5) | |
Lymphatic invasion | 0.1 | ||
Negative | 1 (8.3) | 11 (91.7) | |
Positive | 42 (35.6) | 76 (64.4) | |
Venous invasion | 1 | ||
Negative | 8 (30.8) | 18 (69.2) | |
Positive | 35 (33.7) | 69 (66.3) | |
Peritoneal metastasis | 1 | ||
Negative | 43 (33.3) | 86 (66.7) | |
Positive | 0 (0) | 1 (100) | |
Hematogenous metastasis | 0.6 | ||
Negative | 41 (32.5) | 85 (67.5) | |
Positive | 2(50) | 2(50) | |
T (UICC-TNM 8th) | 0.89 | ||
T1 | 3 (27.3) | 8 (72.7) | |
T2 | 6(30) | 14(70) | |
T3 | 17 (31.5) | 37 (68.5) | |
T4 | 17 (37.8) | 28 (62.2) | |
N (UICC-TNM 8th) | 0.078 | ||
N0 | 22 (27.5) | 58 (72.5) | |
N1 | 20 (40.8) | 29 (59.2) | |
N2 | 1 (100) | 0 (0) | |
Stage (UICC-TNM 8th) | 0.2 | ||
I | 4 (20) | 16 (80) | |
II | 16 (28.1) | 41 (71.9) | |
III | 20 (43.5) | 26 (56.5) | |
IV | 3 (42.9) | 4 (57.1) | |
Adjuvant chemotherapy (each stage) | 0.12 | ||
I | 0 (0) | 0 (0) | |
II | 4 (16.7) | 20 (83.4) | |
III | 15 (40.5) | 22 (59.5) | |
IV | 1 (20) | 4 (80) |